PFS Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
PFS Partners's LLY Position: Q2 2026 in Review
PFS Partners increased its Eli Lilly (LLY) stake by 0.31% in Q2 2026, buying an estimated $1.02K and bringing the position to 321 shares worth $384K. The position accounts for 0.16% of the portfolio, ranked #63.
PFS Partners first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- PFS Partners held 321 shares of Eli Lilly worth $384K as of Q2 2026.
- PFS Partners bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
- Eli Lilly made up 0.16% of PFS Partners's portfolio in Q2 2026, its #63 holding.
- PFS Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.